Anavex Life Valuation
| AVXL Stock | USD 9.46 0.43 4.76% |
At this time, the firm appears to be undervalued. Anavex Life Sciences shows a prevailing Real Value of $18.73 per share. The current price of the firm is $9.46. Our model approximates the value of Anavex Life Sciences from analyzing the firm fundamentals such as current valuation of 663.41 M, and Return On Equity of -0.3 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Anavex Life's valuation include:
Price Book 6.1809 | Enterprise Value 663.4 M | Enterprise Value Ebitda (5.54) |
Undervalued
Today
Please note that Anavex Life's price fluctuation is somewhat reliable at this time. Calculation of the real value of Anavex Life Sciences is based on 3 months time horizon. Increasing Anavex Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Anavex stock is determined by what a typical buyer is willing to pay for full or partial control of Anavex Life Sciences. Since Anavex Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Anavex Stock. However, Anavex Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.46 | Real 18.73 | Target 47.75 | Hype 9.08 |
The intrinsic value of Anavex Life's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Anavex Life's stock price.
Estimating the potential upside or downside of Anavex Life Sciences helps investors to forecast how Anavex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Anavex Life more accurately as focusing exclusively on Anavex Life's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Anavex Life's intrinsic value based on its ongoing forecasts of Anavex Life's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Anavex Life's closest peers.
Anavex Life Cash |
|
Anavex Valuation Trend
Knowing Anavex Life's actual value is paramount for traders when making sound investment determinations. Using both Anavex Life's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Anavex Life Total Value Analysis
Anavex Life Sciences is presently anticipated to have valuation of 663.41 M with market capitalization of 802.17 M, debt of 12.53 M, and cash on hands of 149.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Anavex Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
663.41 M | 802.17 M | 12.53 M | 149.16 M |
Anavex Life Asset Utilization
One of the ways to look at asset utilization of Anavex is to check how much profit was generated for every dollar of assets it reports. Anavex Life Sciences shows a negative utilization of assets of -0.2 percent, losing $0.002043 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Anavex Life Sciences shows how unproductive it operates for each dollar spent on its assets.Anavex Life Ownership Allocation
Anavex Life holds a total of 84.8 Million outstanding shares. 30% of Anavex Life Sciences outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Anavex Life Profitability Analysis
Net Loss for the year was (47.51 M) with profit before overhead, payroll, taxes, and interest of 0.About Anavex Life Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Anavex Life Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Anavex Life Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Anavex Life's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Anavex Life's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Anavex Life. We calculate exposure to Anavex Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Anavex Life's related companies.Anavex Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Anavex Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 79.8 M |
Anavex Life Current Valuation Indicators
Anavex Life's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Anavex Life's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Anavex Life, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Anavex Life's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Anavex Life's worth.When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.